Egbert Smit News Today

Fast, Ad-Free News Updates

Stay updated with breaking news from Egbert Smit. Real-time updates on events, politics, business and more.

Dutch-based MLA Diagnostics raises funds for clinical trials in tailored skin cancer treatments

December 4, 2023

Netherlands-based MLA Diagnostics, a company focused on enhancing personalised treatments for skin cancer patients, has secured fresh funding to advance its

Manon Van Engeland Egbert Smit Maastricht University Medical Center Health Ventures Limburg Startup Capital Fund Health Impact Fund

Source: siliconcanals.com

Merck: European Commission Approves TEPMETKO (tepotinib) for Patients with Advanced NSCLC with METex14 Skipping Alterations

February 18, 2022

TEPMETKO is the first and only oral MET inhibitor to be approved in the European Economic Area for treating adult patients with advanced NSCLC harboring alterations leading to METex14 skipping,

United States Egbert Smit Anne Marie Baird Andrew Paterson European Commission Drug Administration

Source: finanznachrichten.de

Explore More Categories

World News India News Business Technology Sports Entertainment Health Science

Navigation

Egbert Smit News Today

Dutch-based MLA Diagnostics raises funds for clinical trials in tailored skin cancer treatments

Merck: European Commission Approves TEPMETKO (tepotinib) for Patients with Advanced NSCLC with METex14 Skipping Alterations

Explore More Categories